Summit Therapeutics Sub, Inc.
Executive Director, HCP Marketing Lung Lead
Summit Therapeutics Sub, Inc., Princeton, New Jersey, us, 08543
Career Opportunities with Summit Therapeutics Sub, Inc.
A great place to work.
Careers At Summit Therapeutics Sub, Inc.
Current job opportunities are posted here as they become available.
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medicalなの needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR‑mutated, locally advanced or metastatic non‑squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi‑3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role: We are seeking an Executive Director of HCP Marketing – Lung Lead to join Summit’s Commercial team. As a key member of the commercial team reporting to the VP of Marketing, you will shape the strategic vision and lead the US Lung Marketing strategy and launch execution for Non‑Small Cell Lung Cancer (NSCLC).
You will drive cross‑functional readiness and execute integrated HCP marketing plans to ensure successful launches and rapid growth.
Role and Responsibilities
Lead the overall (multiple indications) US Lung HCP Marketing strategy and launch execution, including messaging and go‑to‑market planning across HCP and account segments
Drive commercial launch readiness and ensure alignment across Medical Affairs, Market Access and Sales and Marketing Operations
Partner with Omnichannel and Patient leads to ensure alignment with brand strategy across tactics
Lead a team of marketers who are individually laser focused on specific NSCLC indications and take responsibility for achieving cohesion at the brand level for NSCLC indications
Translate complex clinical and scientific data into compelling, differentiated brand narratives that resonate with stakeholders
Oversee marketing campaigns, content creation and tactical planning
Partner closely with Sales Leadership and Field Teams to translate brand strategy into actionable field tactics, tools, and messaging that drives executional excellence
Work with field insights and analytics to identify market opportunities, feedback trends, and competitive intelligence to continuously refine brand tactics
Develop and maintain relationships with key stakeholders, including healthcare providers, payers, and advocacy groups
Manage budget, agencies, and vendors to ensure high‑quality, efficient execution and fiscal discipline
Lead, mentor and empower cross‑functional teams, fostering a collaborative and high‑performing culture
Travel as needed (25%) to support business priorities and engage with key stakeholders.
All other duties as assigned
Experience, Education and Specialized Knowledge and Skills
Bachelor’s degree in Business, Marketing, or a related field; advanced degree a plus
Minimum of 12+ years of pharmaceutical/biotech commercial experience, including significant oncology brand leadership including NSCLC.
Proven success launching first‑in‑class or specialty oncology medicines in the US
Deep understanding of oncology market dynamics, account and HCP engagement
Demonstrated ability to translate scientific data into clear strategic positioning and communication
Excellent strategic thinking, communication, and leadership skills
In‑depth knowledge of U.S. oncology healthcare segments
Successful record of achieving and maintaining compliance with regulatory, legaldrug, and operational rules
Ability to travel to support business priorities
The pay range for this role is $245,000‑$307,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable Oculus.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
#J-18808-Ljbffr
A great place to work.
Careers At Summit Therapeutics Sub, Inc.
Current job opportunities are posted here as they become available.
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medicalなの needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR‑mutated, locally advanced or metastatic non‑squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi‑3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first‑line metastatic NSCLC.
HARMONi‑GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role: We are seeking an Executive Director of HCP Marketing – Lung Lead to join Summit’s Commercial team. As a key member of the commercial team reporting to the VP of Marketing, you will shape the strategic vision and lead the US Lung Marketing strategy and launch execution for Non‑Small Cell Lung Cancer (NSCLC).
You will drive cross‑functional readiness and execute integrated HCP marketing plans to ensure successful launches and rapid growth.
Role and Responsibilities
Lead the overall (multiple indications) US Lung HCP Marketing strategy and launch execution, including messaging and go‑to‑market planning across HCP and account segments
Drive commercial launch readiness and ensure alignment across Medical Affairs, Market Access and Sales and Marketing Operations
Partner with Omnichannel and Patient leads to ensure alignment with brand strategy across tactics
Lead a team of marketers who are individually laser focused on specific NSCLC indications and take responsibility for achieving cohesion at the brand level for NSCLC indications
Translate complex clinical and scientific data into compelling, differentiated brand narratives that resonate with stakeholders
Oversee marketing campaigns, content creation and tactical planning
Partner closely with Sales Leadership and Field Teams to translate brand strategy into actionable field tactics, tools, and messaging that drives executional excellence
Work with field insights and analytics to identify market opportunities, feedback trends, and competitive intelligence to continuously refine brand tactics
Develop and maintain relationships with key stakeholders, including healthcare providers, payers, and advocacy groups
Manage budget, agencies, and vendors to ensure high‑quality, efficient execution and fiscal discipline
Lead, mentor and empower cross‑functional teams, fostering a collaborative and high‑performing culture
Travel as needed (25%) to support business priorities and engage with key stakeholders.
All other duties as assigned
Experience, Education and Specialized Knowledge and Skills
Bachelor’s degree in Business, Marketing, or a related field; advanced degree a plus
Minimum of 12+ years of pharmaceutical/biotech commercial experience, including significant oncology brand leadership including NSCLC.
Proven success launching first‑in‑class or specialty oncology medicines in the US
Deep understanding of oncology market dynamics, account and HCP engagement
Demonstrated ability to translate scientific data into clear strategic positioning and communication
Excellent strategic thinking, communication, and leadership skills
In‑depth knowledge of U.S. oncology healthcare segments
Successful record of achieving and maintaining compliance with regulatory, legaldrug, and operational rules
Ability to travel to support business priorities
The pay range for this role is $245,000‑$307,000 annually. Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable Oculus.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.
#J-18808-Ljbffr